New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection
Main Authors: | Shijia Yan, Haixia Sun, Xianzhang Bu, Guohui Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00912/full |
Similar Items
-
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein
by: Lee Makowski, et al.
Published: (2021-01-01) -
RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections – novel targets to treat COVID‐19 patients?
by: Ingrid Carvacho, et al.
Published: (2021-01-01) -
Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
by: Matteo Colombo, et al.
Published: (2010-01-01) -
Status and Advances of RGD Molecular Imaging in Lung Cancer
by: Ning YUE, et al.
Published: (2014-12-01) -
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
by: Sujin Kang, et al.
Published: (2020-08-01)